The goal for this year’s FDA Townhall at The MedTech Conference was to have more of an interactive session, Janet Trunzo, senior executive vice president, technology and regulatory affairs, AdvaMed, told the audience. Attendees were asked to pose their questions to the panel, which included Jeffrey Shuren, director of FDA's CDRH; Capt. Raquel Peat, PhD, director of the Office of Orthopedic Devices in CDRH, Suzanne Schwartz, MD MBA, deputy director, Office of Strategic Partnerships & Technology Innovation, CDRH; Michelle Tarver, director of Patient Science & Engagement at CDRH; and Bill Maisel, chief medical officer and director, Office of Product Evaluation and Quality at CDRH.

Read on for a few updates from FDA as panelists answered audience questions.